Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


Articles published in Eur J Endocrinol

Retrieve available abstracts of 61 articles:
HTML format
Text format



Single Articles


    August 2018
  1. OSSWALD A, Deutschbein T, Berr CM, Plomer E, et al
    Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
    Eur J Endocrinol. 2018;179:109-116.
    PubMed     Text format     Abstract available


  2. BILLETER AT, de la Garza Herrera JR, Scheurlen KM, Nickel F, et al
    MANAGEMENT OF ENDOCRINE DISEASE: Which metabolic procedure? Comparing outcomes in sleeve gastrectomy and Roux-en Y gastric bypass.
    Eur J Endocrinol. 2018;179:R77-R93.
    PubMed     Text format     Abstract available


  3. MICHAEL BESSER G, Pfeiffer RF, Thorner MO
    ANNIVERSARY REVIEW: 50 years since the discovery of bromocriptine.
    Eur J Endocrinol. 2018;179:R69-R75.
    PubMed     Text format     Abstract available


    July 2018
  4. MENDOZA LC, Harreiter J, Simmons D, Desoye G, et al
    Risk factors for hyperglycemia in pregnancy in the DALI study differ by period of pregnancy and OGTT time point.
    Eur J Endocrinol. 2018;179:39-49.
    PubMed     Text format     Abstract available


    June 2018
  5. ANDERSEN MS, Glintborg D
    Diagnosis and follow-up of type 2 diabetes in women with PCOS. A role of OGTT?
    Eur J Endocrinol. 2018 Jun 19. pii: EJE-18-0237. doi: 10.1530/EJE-18-0237.
    PubMed     Text format     Abstract available


  6. KNOP FK
    EJE PRIZE 2018: A gut feeling about glucagon.
    Eur J Endocrinol. 2018;178:R267-R280.
    PubMed     Text format     Abstract available


    May 2018
  7. SHEN Y, Wang P, Wang L, Zhang S, et al
    Gestational diabetes with diabetes and prediabetes risks: A large observational study.
    Eur J Endocrinol. 2018 May 9. pii: EJE-18-0130. doi: 10.1530/EJE-18-0130.
    PubMed     Text format     Abstract available


  8. HONKA MJ, Latva-Rasku A, Bucci M, Virtanen KA, et al
    Insulin-stimulated glucose uptake in skeletal muscle, adipose tissue and liver: a positron emission tomography study.
    Eur J Endocrinol. 2018;178:523-531.
    PubMed     Text format     Abstract available


    April 2018
  9. DI CAMILLO B, Hakaste L, Sambo F, Gabriel R, et al
    HAPT2D: high accuracy of prediction of T2D with a model combining basic and advanced data depending on availability.
    Eur J Endocrinol. 2018;178:331-341.
    PubMed     Text format     Abstract available


  10. ESTERLINE RL, Vaag A, Oscarsson J, Vora J, et al
    MECHANISMS IN ENDOCRINOLOGY: SGLT2 inhibitors: clinical benefits by restoration of normal diurnal metabolism?
    Eur J Endocrinol. 2018;178:R113-R125.
    PubMed     Text format     Abstract available


    March 2018
  11. WHICHER C, Price HC, Holt RI
    Antipsychotic Medication and Type 2 Diabetes and Impaired Glucose Regulation.
    Eur J Endocrinol. 2018 Mar 20. pii: EJE-18-0022. doi: 10.1530/EJE-18-0022.
    PubMed     Text format     Abstract available


  12. RYS P, Ludwig-Slomczynska AH, Cyganek K, Malecki MT, et al
    Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes mellitus - a systematic review and meta-analysis of randomised controlled trials and observational studies.
    Eur J Endocrinol. 2018 Mar 15. pii: EJE-17-0804. doi: 10.1530/EJE-17-0804.
    PubMed     Text format     Abstract available


  13. BELLO-CHAVOLLA OY, Almeda-Valdes P, Gomez-Velasco D, Viveros-Ruiz T, et al
    METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes.
    Eur J Endocrinol. 2018 Mar 13. pii: EJE-17-0883. doi: 10.1530/EJE-17-0883.
    PubMed     Text format     Abstract available


  14. PARK SK, Ryoo JH, Oh CM, Choi JM, et al
    Longitudinally evaluated the relationship between body fat percentage and the risk for type 2 diabetes mellitus: Korean Genome and Epidemiology Study (KoGES).
    Eur J Endocrinol. 2018 Mar 9. pii: EJE-17-0868. doi: 10.1530/EJE-17-0868.
    PubMed     Text format     Abstract available


    February 2018
  15. LEVELT E, Gulsin GS, Neubauer S, McCann GP, et al
    MECHANISMS IN ENDOCRINOLOGY: Diabetic Cardiomyopathy - Pathophysiology and Potential Metabolic Interventions.
    Eur J Endocrinol. 2018 Feb 12. pii: EJE-17-0724. doi: 10.1530/EJE-17-0724.
    PubMed     Text format     Abstract available


  16. SUJANA C, Huth C, Zierer A, Meesters S, et al
    Association of fetuin-A with incident type 2 diabetes: Results from the MONICA/KORA Augsburg study and a systematic meta-analysis.
    Eur J Endocrinol. 2018 Feb 8. pii: EJE-17-1053. doi: 10.1530/EJE-17-1053.
    PubMed     Text format     Abstract available


  17. JENSEN RB, Thankamony A, Holst KK, Janssen JAMJL, et al
    Genetic influence on the associations between IGF-I and glucose metabolism in a cohort of elderly twins.
    Eur J Endocrinol. 2018;178:155-163.
    PubMed     Text format     Abstract available


  18. SCOTT ES, Long GV, Guminski A, Clifton-Bligh RJ, et al
    The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma.
    Eur J Endocrinol. 2018;178:175-182.
    PubMed     Text format     Abstract available


    January 2018
  19. VASILEIOU V, Kyratzoglou E, Paschou SA, Kyprianou M, et al
    The impact of environmental temperature on the diagnosis of gestational diabetes mellitus.
    Eur J Endocrinol. 2018 Jan 23. pii: EJE-17-0730. doi: 10.1530/EJE-17-0730.
    PubMed     Text format     Abstract available


  20. GHANIM H, Dhindsa S, Abuaysheh S, Batra M, et al
    Diminished Androgen and Estrogen Receptors and Aromatase Levels in Hypogonadal Diabetic Men: Reversal with Testosterone.
    Eur J Endocrinol. 2018 Jan 16. pii: EJE-17-0673. doi: 10.1530/EJE-17-0673.
    PubMed     Text format     Abstract available


  21. QVIGSTAD E
    The diversity of gestational diabetes - a therapeutic challenge.
    Eur J Endocrinol. 2018 Jan 16. pii: EJE-18-0012. doi: 10.1530/EJE-18-0012.
    PubMed     Text format     Abstract available


    November 2017
  22. CHILOIRO S, De Marinis L
    Letter to the editor: Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis.
    Eur J Endocrinol. 2017 Nov 15. pii: EJE-17-0910. doi: 10.1530/EJE-17-0910.
    PubMed     Text format     Abstract available


    October 2017
  23. GANTE I, Melo L, Dores J, Ruas L, et al
    Metformin in Gestational Diabetes Mellitus: predictors of poor response.
    Eur J Endocrinol. 2017 Oct 25. pii: EJE-17-0486. doi: 10.1530/EJE-17-0486.
    PubMed     Text format     Abstract available


  24. CHANTZICHRISTOS D, Persson A, Eliasson B, Miftaraj M, et al
    Incidence, prevalence, and seasonal onset variation of Addison's disease among persons with type 1 diabetes mellitus: nationwide, matched, cohort studies.
    Eur J Endocrinol. 2017 Oct 24. pii: EJE-17-0751. doi: 10.1530/EJE-17-0751.
    PubMed     Text format     Abstract available


    August 2017
  25. LUPI I, Cosottini M, Caturegli P, Manetti L, et al
    Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis.
    Eur J Endocrinol. 2017;177:127-135.
    PubMed     Text format     Abstract available


    July 2017
  26. HERDER C, Kannenberg JM, Niersmann C, Huth C, et al
    Independent and opposite associations of serum levels of omentin-1 and adiponectin with increases of glycaemia and incident type 2 diabetes in an older population: KORA F4/FF4 Study.
    Eur J Endocrinol. 2017 Jul 5. pii: EJE-17-0100. doi: 10.1530/EJE-17-0100.
    PubMed     Text format     Abstract available


    June 2017
  27. DIAMANTI-KANDARAKIS E, Dattilo M, Macut D, Duntas L, et al
    MECHANISMS IN ENDOCRINOLOGY: Aging and anti-aging: a Combo-Endocrinology overview.
    Eur J Endocrinol. 2017;176:R283-R308.
    PubMed     Text format     Abstract available


    May 2017
  28. MAGNUSSEN LV, Andersen PE, Diaz A, Ostojic JM, et al
    MR-spectroscopy of hepatic-fat and adiponectin and leptin levels during testosterone therapy in type 2 diabetes. A randomized, double-blinded, placebo-controlled trial.
    Eur J Endocrinol. 2017 May 18. pii: EJE-17-0071. doi: 10.1530/EJE-17-0071.
    PubMed     Text format     Abstract available


  29. WANG B, An X, Shi X, Zhang JA, et al
    MANAGEMENT OF ENDOCRINE DISEASE: Suicide risk in patients with diabetes: a systematic review and meta-analysis.
    Eur J Endocrinol. 2017 May 16. pii: EJE-16-0952. doi: 10.1530/EJE-16-0952.
    PubMed     Text format     Abstract available


  30. ESPES D, Lau Borjesson J, Carlsson PO
    MECHANISMS IN ENDOCRINOLOGY: Towards the clinical translation of stem cell therapy for type 1 diabetes.
    Eur J Endocrinol. 2017 May 9. pii: EJE-17-0080. doi: 10.1530/EJE-17-0080.
    PubMed     Text format     Abstract available


  31. GARRAHY A, Sherlock M, Thompson CJ
    MANAGEMENT OF ENDOCRINE DISEASE: Neuroendocrine surveillance and management of neurosurgical patients.
    Eur J Endocrinol. 2017;176:R217-R233.
    PubMed     Text format     Abstract available


    April 2017
  32. HE Y, Qian H, Xu L, Zhang S, et al
    Association Between Estimated Glomerular Filtration Rate and Outcomes in Patients with Diabetic Foot Ulcers: a 3-year Follow-up Study.
    Eur J Endocrinol. 2017 Apr 19. pii: EJE-17-0070. doi: 10.1530/EJE-17-0070.
    PubMed     Text format     Abstract available


  33. CHEMAITILLY W, Cohen LE
    DIAGNOSIS OF ENDOCRINE DISEASE: Endocrine late-effects of childhood cancer and its treatments.
    Eur J Endocrinol. 2017;176:R183-R203.
    PubMed     Text format     Abstract available


    March 2017
  34. HANSEN CR, Perrild H, Koefoed BG, Zander M, et al
    Video conferences preceded by uploading of measurements as add-on to standard care among patients with type 2 diabetes not responding to standard regimens - a randomized controlled trial.
    Eur J Endocrinol. 2017 Mar 21. pii: EJE-16-0811. doi: 10.1530/EJE-16-0811.
    PubMed     Text format     Abstract available


  35. HYGUM K, Starup-Linde J, Harslof T, Vestergaard P, et al
    MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis.
    Eur J Endocrinol. 2017;176:R137-R157.
    PubMed     Text format     Abstract available


  36. SCOTT R, Van Vliet G, Deladoey J
    Association of adrenal insufficiency with insulin-dependent diabetes mellitus in a patient with inactivating mutations in nicotinamide nucleotide transhydrogenase: a phenocopy of the animal model.
    Eur J Endocrinol. 2017;176:C1-C2.
    PubMed     Text format    


    February 2017
  37. MOEN GH, Sommer C, Prasad R, Sletner L, et al
    MECHANISMS IN ENDOCRINOLOGY: EPIGENETIC MODIFICATIONS AND GESTATIONAL DIABETES; A SYSTEMATIC REVIEW OF PUBLISHED LITERATURE.
    Eur J Endocrinol. 2017 Feb 23. pii: EJE-16-1017. doi: 10.1530/EJE-16-1017.
    PubMed     Text format     Abstract available


  38. HJORTEBJERG R, Laugesen E, Hoyem P, Oxvig C, et al
    The IGF system in patients with type 2 diabetes: associations with markers of cardiovascular target organ damage.
    Eur J Endocrinol. 2017 Feb 8. pii: EJE-16-0940. doi: 10.1530/EJE-16-0940.
    PubMed     Text format     Abstract available


  39. GIORDA CB, Carna P, Romeo F, Costa G, et al
    Prevalence, incidence, and associated co-morbidities of treated hypothyroidism. An update from a European population.
    Eur J Endocrinol. 2017 Feb 8. pii: EJE-16-0559. doi: 10.1530/EJE-16-0559.
    PubMed     Text format     Abstract available


  40. BRONS C, Grunnet LG
    MECHANISMS IN ENDOCRINOLOGY: Skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes: a causal mechanism or an innocent bystander?
    Eur J Endocrinol. 2017;176:R67-R78.
    PubMed     Text format     Abstract available


  41. LESEN E, Granfeldt D, Houchard A, Dinet J, et al
    Comorbidities, treatment patterns and cost-of-illness of acromegaly in Sweden: a register-linkage population-based study.
    Eur J Endocrinol. 2017;176:203-212.
    PubMed     Text format     Abstract available


    January 2017
  42. CHANTZICHRISTOS D, Persson A, Eliasson B, Miftaraj M, et al
    Mortality in patients with diabetes mellitus and Addison's disease: a nationwide, matched, observational cohort study.
    Eur J Endocrinol. 2017;176:31-39.
    PubMed     Text format     Abstract available


    December 2016
  43. LOFVENBORG JE, Andersson T, Carlsson PO, Dorkhan M, et al
    Sweetened beverage intake and risk of latent autoimmune diabetes in adults (LADA) and type 2 diabetes.
    Eur J Endocrinol. 2016;175:605-614.
    PubMed     Text format     Abstract available


    November 2016
  44. BREUER TG, Borker L, Quast DR, Tannapfel A, et al
    Impact of proton pump inhibitor treatment on pancreatic beta-cell area and beta-cell proliferation in humans.
    Eur J Endocrinol. 2016;175:467-76.
    PubMed     Text format     Abstract available


  45. SARDELLA C, Cappellani D, Urbani C, Manetti L, et al
    Disease activity and lifestyle influence comorbidities and cardiovascular events in patients with acromegaly.
    Eur J Endocrinol. 2016;175:443-53.
    PubMed     Text format     Abstract available


    October 2016
  46. SMITS MM, Tonneijck L, Muskiet MH, Hoekstra T, et al
    Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial.
    Eur J Endocrinol. 2016 Oct 24. pii: EJE-16-0507.
    PubMed     Text format     Abstract available


  47. DE ARAUJO IM, Salmon CE, Nahas AK, Nogueira-Barbosa MH, et al
    Marrow Adipose Tissue Spectrum in Obesity and Type 2 Diabetes Mellitus.
    Eur J Endocrinol. 2016 Oct 5. pii: EJE-16-0448.
    PubMed     Text format     Abstract available


  48. KURSTJENS S, De Baaij J, Bouras H, Bindels R, et al
    Determinants of hypomagnesemia in patients with type 2 diabetes mellitus.
    Eur J Endocrinol. 2016 Oct 5. pii: EJE-16-0517.
    PubMed     Text format     Abstract available


  49. SBARDELLA E, Joseph RN, Jafar-Mohammadi B, Isidori AM, et al
    Pituitary stalk thickening: the role of an innovative MRI imaging analysis which may assist in determining clinical management.
    Eur J Endocrinol. 2016;175:255-63.
    PubMed     Text format     Abstract available


    September 2016
  50. ZAHARENKO L, Kalnina I, Geldnere K, Konrade I, et al
    Single nucleotide polymorphisms in the intergenic region between metformin transporter OCT2 and OCT3 genes are associated with short-term response to metformin monotherapy in type 2 diabetes mellitus patients.
    Eur J Endocrinol. 2016 Sep 8. pii: EJE-16-0347.
    PubMed     Text format     Abstract available


  51. CARREIRO MP, Lauria MW, Naves GN, Miranda PA, et al
    Seventy two-hour glucose monitoring profiles in mild gestational diabetes mellitus: differences from healthy pregnancies and influence of diet counseling.
    Eur J Endocrinol. 2016;175:201-9.
    PubMed     Text format     Abstract available


  52. DAL J, Feldt-Rasmussen U, Andersen M, Kristensen LO, et al
    Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study.
    Eur J Endocrinol. 2016;175:181-90.
    PubMed     Text format     Abstract available


    August 2016
  53. LARCHER S, Gauchez AS, Lablanche S, Pepin JL, et al
    Impact of sleep behavior on glycemic control in type 1 diabetes: the role of social jetlag.
    Eur J Endocrinol. 2016 Aug 16. pii: EJE-16-0188.
    PubMed     Text format     Abstract available


  54. HERDER C, Faerch K, Carstensen-Kirberg M, Lowe G, et al
    Biomarkers of subclinical inflammation and increases in glycaemia, insulin resistance and beta-cell function in non-diabetic individuals: the Whitehall II study.
    Eur J Endocrinol. 2016 Aug 4. pii: EJE-16-0528.
    PubMed     Text format     Abstract available


  55. WU XY, Lam VC, Yu YF, Ho RS, et al
    Epidemiological characteristics and methodological quality of meta-analyses on diabetes mellitus treatment: a systematic review.
    Eur J Endocrinol. 2016 Aug 4. pii: EJE-16-0172.
    PubMed     Text format     Abstract available


  56. KRUL-POEL YH, Ter Wee M, Lips P, Simsek S, et al
    MANAGEMENT OF ENDOCRINE DISEASE: The effect of vitamin D supplementation on glycaemic control in patients with Type 2 Diabetes Mellitus: a systematic review and meta-analysis.
    Eur J Endocrinol. 2016 Aug 2. pii: EJE-16-0391.
    PubMed     Text format     Abstract available


    July 2016
  57. VAN RAALTE DH, Bunck MC, Smits MM, Hoekstra T, et al
    Exenatide Improves Beta-cell Function up to 3 Years of Treatment in Patients with Type 2 Diabetes: a Randomised Controlled Trial.
    Eur J Endocrinol. 2016 Jul 27. pii: EJE-16-0286.
    PubMed     Text format     Abstract available


  58. NOCTOR E, Crowe C, Carmody LA, Saunders JA, et al
    Abnormal glucose tolerance post-gestational diabetes mellitus as defined by International Association of Diabetes and Pregnancy Study Groups criteria.
    Eur J Endocrinol. 2016 Jul 15. pii: EJE-15-1260.
    PubMed     Text format     Abstract available


  59. DAVIS TM, Chubb SA, Davis W
    The relationship between estimated glomerular filtration rate trajectory and all-cause mortality in type 2 diabetes: The Fremantle Diabetes Study.
    Eur J Endocrinol. 2016 Jul 14. pii: EJE-16-0327.
    PubMed     Text format     Abstract available


    June 2016
  60. STEFFENSEN C, Pereira AM, Dekkers OM, Jorgensen JO, et al
    DIAGNOSIS OF ENDOCRINE DISEASE: Prevalence of hypercortisolism in Type 2 Diabetes patients: a systematic review and meta-analysis.
    Eur J Endocrinol. 2016 Jun 27. pii: EJE-16-0434.
    PubMed     Text format     Abstract available


  61. LI P, Shan Z, Zhou L, Xie M, et al
    MECHANISMS IN ENDOCRINOLOGY: Parity and risk of type 2 diabetes: a systematic review and dose-response meta-analysis.
    Eur J Endocrinol. 2016 Jun 22. pii: EJE-16-0321.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: